These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Expression of cadherins and their undercoat proteins (alpha-, beta-, and gamma-catenins and p120) and accumulation of beta-catenin with no gene mutations in synovial sarcoma. Sato H, Hasegawa T, Kanai Y, Tsutsumi Y, Osamura Y, Abe Y, Sakai H, Hirohashi S. Virchows Arch; 2001 Jan; 438(1):23-30. PubMed ID: 11213832 [Abstract] [Full Text] [Related]
27. Characterization of the E-cadherin-catenin complexes in pancreatic carcinoma cell lines. El-Hariry I, Jordinson M, Lemoine N, Pignatelli M. J Pathol; 1999 Jun; 188(2):155-62. PubMed ID: 10398158 [Abstract] [Full Text] [Related]
28. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis. Karayiannakis AJ, Syrigos KN, Polychronidis A, Simopoulos C. Anticancer Res; 2001 Jun; 21(6A):4127-34. PubMed ID: 11911306 [Abstract] [Full Text] [Related]
30. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features. Wei Y, Van Nhieu JT, Prigent S, Srivatanakul P, Tiollais P, Buendia MA. Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663 [Abstract] [Full Text] [Related]
31. Role of E-cadherin, alpha-, beta-, and gamma-catenins, and p120 (cell adhesion molecules) in prolactinoma behavior. Qian ZR, Li CC, Yamasaki H, Mizusawa N, Yoshimoto K, Yamada S, Tashiro T, Horiguchi H, Wakatsuki S, Hirokawa M, Sano T. Mod Pathol; 2002 Dec; 15(12):1357-65. PubMed ID: 12481018 [Abstract] [Full Text] [Related]
32. Beta- and gamma-catenin expression in oral squamous cell carcinomas. Lo Muzio L, Staibano S, Pannone G, Grieco M, Mignogna MD, Cerrato A, Testa NF, De Rosa G. Anticancer Res; 1999 Dec; 19(5B):3817-26. PubMed ID: 10628318 [Abstract] [Full Text] [Related]
33. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. De Leeuw WJ, Berx G, Vos CB, Peterse JL, Van de Vijver MJ, Litvinov S, Van Roy F, Cornelisse CJ, Cleton-Jansen AM. J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256 [Abstract] [Full Text] [Related]
34. Downregulation of E-cadherin and its undercoat proteins in pituitary growth hormone cell adenomas with prominent fibrous bodies. Xu B, Sano T, Yoshimoto K, Yamada S. Endocr Pathol; 2002 Dec; 13(4):341-51. PubMed ID: 12665652 [Abstract] [Full Text] [Related]
35. Cadherin-catenin complex: protein interactions and their implications for cadherin function. Aberle H, Schwartz H, Kemler R. J Cell Biochem; 1996 Jun 15; 61(4):514-23. PubMed ID: 8806074 [Abstract] [Full Text] [Related]
38. The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin. Rubinfeld B, Souza B, Albert I, Munemitsu S, Polakis P. J Biol Chem; 1995 Mar 10; 270(10):5549-55. PubMed ID: 7890674 [Abstract] [Full Text] [Related]
39. Differential expression of E-cadherin and beta catenin in primary and metastatic Wilms's tumours. Alami J, Williams BR, Yeger H. Mol Pathol; 2003 Aug 10; 56(4):218-25. PubMed ID: 12890743 [Abstract] [Full Text] [Related]
40. The expression of E-cadherin and catenins in sporadic colorectal carcinoma. El-Bahrawy MA, Poulsom R, Jeffery R, Talbot I, Alison MR. Hum Pathol; 2001 Nov 10; 32(11):1216-24. PubMed ID: 11727261 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]